Do you consider use of TIP as first-line therapy for poor-risk advanced germ cell tumors?

Unequivocally no. TIP seems clearly more toxic and achieves results no different than VIP or BEP given at high volume centers. TIP will not ever be compared to either and is going nowhere.

In my view and the view of other testis cancer experts, the most important aspect is that these uncommon patien...